GLAXF News and Press, GlaxoSmithKline Plc From 09/11/23

2023-09-11 11:49:04 ET Summary Bayer's stock has had a volatile performance, reaching highs and lows since December 2022, when I first wrote about this company. Both from a relative and intrinsic standpoint, Bayer seems to be severely undervalued. Bayer has both short-ter...

2023-09-09 03:17:14 ET Summary Wall Street underestimates the prospects of Pfizer and Gilead Sciences, given their significant role in developing vaccines and medicines against COVID-19. Gilead Sciences' revenue has remained stable in recent quarters, unlike Pfizer, whose demand f...

2023-09-07 12:59:08 ET GSK plc (GSK) Citi's 18th Annual BioPharma Conference September 07, 2023 08:50 A.M. ET Company Participants Phil Dormitzer - SVP, Head of Vaccines R&D Conference Call Participants Andrew Baum - Citi Presentation Andrew...

2023-08-24 02:20:26 ET Summary Bristol-Myers has a strong history of investment outperformance during equity bear markets and recessions. The company is uniquely undervalued, with a low 8x P/E and nearly 4% cash dividend yield. After a weak first half of 2023, shares may rebou...

2023-08-21 13:57:06 ET Summary On August 1, Merck released its financial report for the second quarter of 2023, which showed excellent results. Merck's revenue for the second quarter of 2023 was $15.04 billion, up 3.8% from the previous quarter and up 3.1% from the second quarter ...

2023-07-30 01:20:34 ET Summary AstraZeneca's revenue for the second quarter of 2023 was $11.42 billion, up 5% from the previous quarter and 6% from the second quarter of 2022. At the end of June 2023, AstraZeneca's total debt was about $30.8 billion, down $1.68 billion from the pr...

2023-07-29 08:03:02 ET Summary Bristol-Myers Squibb's revenue for the second quarter of 2023 was $11.23 billion, down 0.97% from the previous quarter and 5.6% from the second quarter of 2022. Sales of Opdualag, an FDA-approved drug for treating patients with unresectable or metast...

2023-07-26 13:59:14 ET Summary GSK plc's stock price has barely moved YTD. But with upgraded full-year expectations for both turnover and profits, coupled with attractive valuations, it looks set to rise. The outlook upgrade follows the better-than-expected 11% YoY sales increase ...

2023-07-26 11:33:05 ET GSK plc (GSK) Q2 2023 Earnings Conference Call July 26, 2023 07:00 AM ET Company Participants Nick Stone - Senior Vice President, Head, Investor Relations Emma Walmsley - Chief Executive Officer Tony Wood - Chief Scientific Officer Luke...

2023-07-21 11:08:50 ET Summary On July 27, 2023, Bristol-Myers Squibb, one of the leaders in the global cancer and immunology therapeutics market, will release its financial report for the second quarter of 2023. In the first half of 2023, the company delighted investors with nume...